Back

Replacing statins with PCSK9-inhibitors and delaying treatment until 18 years of age in patients with familial hypercholesterolaemia is not a good idea

European Heart Journal

29 March 2016
Organised by: Logo
Read full article
ESC Journals

Contributors

Gisle Langslet
Gisle Langslet

Author

You may be interested in
thumbnail
Congress Presentation
Lipids in the young
29 August 2026
thumbnail
Congress Presentation
Effectiveness of PCSK9 inhibitors in homozygous familial hypercholesterolemia: insights from a Saudi Arabia genetic population
3 April 2025
thumbnail
Congress Presentation
NATURE-LEGACY: Long term legacy benefit of Lowering LDL and SBP
1 September 2025
thumbnail
Congress Session
Multi-disciplinary approaches to lipid management
24 June 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources